Tooling ownership is the line that actually separates OEM from private label

I have watched a buyer reject a perfectly good lot of 9 mm screw-thread vials because the certificate of analysis listed a manufacturer whose name he did not recognize. The vials met every dimensional callout on the drawing, passed 0.5 in-lb torque retention, and held 15 psi for 90 seconds on the leak bench. He rejected them anyway, because his method SOP named a brand and the brand on the carton did not match. That single event is the cleanest illustration of the OEM vs private label cod vial difference I know. The physical part was identical. The paperwork, the tooling ownership, and the legal identity behind it were not. This article is about that gap, not about pricing and not about what a cod vial does in a method.

When people ask me about the OEM vs private label cod vial difference, they usually mean “which is cheaper” or “which is better.” Both are the wrong question. The question that matters is: who owns the tooling, who controls the recipe, and who carries the liability when the part fails a method check eighteen months from now? Those three answers do not move together, and they do not always line up with the logo on the box. I have sourced cod vials through codvial.com in both models, and the failure modes were different in ways that had nothing to do with the glass.

Forget the marketing definitions. In a factory, OEM and private label are distinguished by who paid for the mold, the die, and the gauges. Everything else follows from that.

An OEM arrangement means the buyer (or the brand) commissioned and owns the tooling. The blow-mold or the vial mold, the septa punch die, the crimp die, the go/no-go ring gauges: those are assets on the buyer’s balance sheet, even when they sit on the supplier’s floor. The supplier runs them under a tooling agreement. If the relationship ends, the tooling comes back or gets transferred, and the next factory produces parts from the same cavity geometry. That is the whole point. The cavity-to-cavity dimensional spread stays where you qualified it, because the cavity did not change.

Private label means the supplier owns the tooling and prints your name on the carton. You are buying finished goods from a catalog the supplier already runs. It is faster, it is usually cheaper at low volume, and it is completely fine as long as you understand that the geometry under your label belongs to someone else and can be re-cut, re-sourced, or quietly moved to a second plant whenever the supplier wants.

What “owns the tooling” buys you in practice

Concrete version. A cod vial drawing I work from calls out an 8-425 GPI thread, a 12 x 32 mm body, and a 6.0 mm neck ID with a +/- 0.15 mm band. If I own the mold, that neck ID is a known cavity number, and I can pull the last three capability studies and see Cpk holding above 1.33. If I am buying private label, I get the supplier’s spec sheet, which says 6.0 mm nominal, and I get whatever the current cavity produces. The spec sheet does not tell me the cavity. The certificate does not tell me the cavity. Only a tooling agreement and a first-article inspection tied to a specific mold do.

This is where the vial insert and the neck finish interact. A 250 µL insert that sits on a shoulder dimension with a 0.2 mm clearance is unforgiving of neck-ID drift. I have seen a private-label lot where the insert seated 0.3 mm high because the neck ID ran to the top of the band, and the autosampler needle bottomed out 1 mm short of the insert floor. The method still ran. The recoveries dropped 4% on the low calibrator. Nobody caught it for three weeks.

The recipe is a separate asset from the tooling, and private label buyers rarely see it

Tooling is geometry. The recipe is everything else: glass composition, annealing profile, the PTFE face formulation on the septum, the silicone durometer, the wash and depyrogenation cycle, the packaging environment. A private-label buyer typically receives a datasheet that lists the recipe at the level of “PTFE/silicone, 45 Shore A.” An OEM buyer with a specification can pin it down.

Why it matters for a cod vial specifically: the closure is doing chemistry. The PTFE face on a 9 mm septum is what stands between your sample and the silicone. If the PTFE film is 0.13 mm on one supplier’s private-label line and 0.10 mm on another, both pass a visual, both pass a puncture test, and both leak the same on day one. They behave differently after 40 punctures and a week at 60 °C. The thinner film coring rate climbs. I have measured it. The difference is real and it is invisible on the carton.

Under OEM, the film thickness, the lamination bond, and the silicone cure are line items in the specification, and a change triggers a notification. Under private label, they are the supplier’s business. If the film supplier changes, you find out when your blanks start showing ghost peaks. That is a recipe problem that looks like a method problem, and it will eat a week of your time before you trace it back to the closure.

Where the recipe shows up in a data set

Three places I check first when a private-label switch goes wrong:

• Blank chromatograms after 24 h at 40 °C. A recipe change in the septum shows up here before it shows up in sample data. If the blank grows a peak at 8.2 minutes, the closure changed, not the method.
• Coring counts on a 20-vial sample. Run every vial to 30 punctures with a fresh needle and count fragments under 100 µm. A good PTFE-faced septum holds under 2% coring rate at 30 punctures. A marginal one hits 6 to 8%.
• Torque retention after autoclave. Crimp to 0.5 in-lb, autoclave at 121 °C for 20 minutes, then re-measure. A recipe with a poorly annealed neck relaxes and drops below 0.35 in-lb. That is a leak waiting to happen on the shelf.

When the brand changes but the factory does not, the paperwork is the only thing that moved

This is the part that confuses procurement most. A single factory can run the same cavity, the same recipe, the same annealing tunnel, and ship the output under four different brand names. Your “new supplier” is the same supplier. Your “new lot” is the same lot with a different label. Nothing about the part changed.

That is not a scandal. It is normal in this industry. The problem is that buyers treat it as a supply-chain event and revalidate the method, which costs weeks and tells them nothing. Or they treat it as a non-event and skip revalidation when the factory actually did change. Both are wrong, and the only way to tell which situation you are in is to know who owns the tooling and who controls the recipe.

A decision checklist for the brand-swap question

When a cod vial arrives under a new label, run this before you touch the method:

Five questions. If all five are “yes,” the brand swap is a paperwork event and the revalidation is a signature. If any are “no,” you have a real qualification in front of you. The trick is that most private-label buyers cannot answer questions two through four, because the supplier will not disclose the recipe. That is not the supplier being difficult. It is the private-label model working as designed. You bought a part, not a specification.

Liability follows the specification, not the label

Here is the part nobody puts in the brochure. If a cod vial causes a method failure and the failure reaches a regulator or a customer audit, the question is: whose specification was violated? Under OEM, you have a drawing, a specification, a first-article report, and a change-notification clause. The liability chain is documented. Under private label, the specification is the supplier’s datasheet, which is deliberately loose. “PTFE/silicone, 9 mm, 45 Shore A” is not a specification. It is a description. You cannot prove a violation against a description.

I have watched a private-label buyer try to hold a supplier accountable for a coring rate that doubled between lots. The supplier’s response was that the datasheet never specified a coring rate. It specified a material and a dimension. Both were met. The buyer had no case, and the method had already been invalidated by the data.

Under OEM, the coring rate is a line item. So is the puncture count at which it was measured. So is the acceptance criterion. The supplier knows this when they bid, and they price it in. You are paying for the specification, not the part. That is the honest answer to “why does OEM cost more,” and it is a different answer than the pricing article gives.

Two field cases where the distinction decided the outcome

Case one: the private-label lot that passed everything except the method

A contract lab switched to a private-label cod vial to save on a mid-volume method. The vials passed incoming inspection: dimensions on the drawing, torque at 0.5 in-lb, leak test at 15 psi. Six weeks in, the low calibrator recoveries on a COD method drifted 5% low. The blanks were clean. The standards were fresh. The instrument was fine. The measurement that identified the problem was a 30-puncture coring count on the suspect lot versus the retained OEM lot. The private-label lot ran 7.4% coring rate; the OEM lot ran 1.6%. The fragments were lodging in the needle and causing partial injections on the low end. The fix was to revert to the OEM source and add a coring count to incoming inspection. The lesson: the private-label supplier met every spec they published. They just never published the one that mattered.

Case two: the OEM tooling transfer that saved a revalidation

A pharma QC group had to move a cod vial from one contract manufacturer to another because the first factory was closing a line. Because they owned the tooling, the mold was transferred, not re-cut. The new factory ran a first-article inspection against the same drawing and hit the same cavity numbers. The neck ID came in at 6.02 mm on the same cavity that had run 6.01 mm at the old plant. The change-notification clause required a method revalidation anyway, but the data package was thin: dimensional, torque, leak, and a 30-puncture coring count, all within the qualified bands. The revalidation closed in nine days instead of the eight weeks a new-source qualification would have taken. The tooling ownership was the entire reason. The recipe came along because the specification traveled with the mold.

What actually changes when you move from one model to the other

If you are moving from private label to OEM, three things change. First, you get a specification you can enforce, which means you can write an incoming inspection that catches drift. Second, you get change notification, which means a recipe change reaches you before it reaches your data. Third, you get a tooling asset, which means you can move factories without re-qualifying geometry. The cost is higher MOQ, longer lead time, and a tooling invoice. The 2ml vial side of the catalog shows the same pattern; the OEM parts carry a drawing, the private-label parts carry a datasheet.

If you are moving from OEM to private label, you are trading all three of those for speed and price. That is a legitimate trade for a method that is not regulated, not audited, and not sensitive to closure chemistry. It is a bad trade for anything that touches a regulated method, and it is a terrible trade for anything where a 4% recovery shift would trigger an investigation.

The middle path most buyers should actually take

There is a third model that gets less airtime than it deserves: OEM tooling with a private-label recipe. You own the mold and the gauges, and you buy the finished part from a supplier who runs their own glass and septum recipe to your drawing. This gets you geometry control without paying for a full specification on every input. It is the right answer for a mid-volume method where the dimensional stack is the risk and the closure chemistry is well understood. Ask for it explicitly. Most suppliers will quote it once they understand you are not asking for a discount, you are asking for a boundary.

For the closure chemistry itself, the reference data from the instrument vendors is worth reading before you write the spec. Agilent’s chromatography consumables documentation and Thermo Fisher’s sample handling references both publish closure bleed and septa selection guidance that is more useful than most supplier datasheets. Restek’s technical library has the clearest write-up I have found on PTFE-faced septum behavior after multiple punctures. And if the method is a regulated one, the primary source is the method itself; the EPA SW-846 test methods are where the closure requirements actually live, not in the supplier’s marketing.

The incoming inspection that tells you which model you are actually in

You can determine which model you are in without asking anyone, by running a five-point inspection on the first lot and comparing it to the retained reference lot:

• Neck ID, 10 vials, micrometer. Report mean and range. A range above 0.10 mm across 10 vials from one carton means the cavity spread is wider than a qualified OEM part should show.
• Torque retention, 5 vials, 0.5 in-lb crimp, 20 min at 121 °C. Post-autoclave value below 0.35 in-lb is a neck-annealing problem.
• Coring count, 5 vials, 30 punctures each. Above 2% fragment rate is a septum recipe problem.
• Blank chromatogram, 3 vials, 24 h at 40 °C. Any peak above the method’s LOQ is a closure chemistry problem.
• Leak test, 10 vials, 15 psi for 90 s. Any failure is a dimensional or crimp problem, and it is the one failure you cannot argue with.

If the lot passes all five against the reference, you are effectively in an OEM relationship whether or not the paperwork says so. If it fails any of them, you are in a private-label relationship and the supplier’s datasheet will not save you. The HPLC consumables catalog is a good place to see how the same logic applies across the rest of the bench; the parts that carry a drawing behave differently from the parts that carry a description, and the difference shows up in exactly these five measurements.

The decision rule

Choose OEM when the cod vial is on a regulated method, when the closure chemistry is part of the analytical risk, or when you cannot afford to re-qualify geometry if the factory moves. Choose private label when the method is not regulated, the closure is not the risk, and you value speed over specification. Do not choose private label and then ask for OEM accountability, and do not choose OEM and then skip the incoming inspection that the specification was written to support. The tooling tells you what the part is. The recipe tells you how it behaves. The label tells you nothing.

References & further reading

Related resources from our lab consumables network:

• Cod Vial at codvial.com
• Vial Insert at hplcinsert.com
• 2Ml Vial at 2mlsamplevial.com
• Hplc Consumables at hplcconsumable.com

External references and standards:

• Agilent chromatography consumables and columns
• Thermo Fisher chromatography and sample handling
• U.S. EPA SW-846 test methods for waste and materials
• Restek technical resources for chromatography